Literature DB >> 20490327

Proposal of an improved histological sub-typing system for lung adenocarcinoma - significant prognostic values for stage I disease.

Koji Okudela1, Tetsukan Woo, Hideaki Mitsui, Takuya Yazawa, Hiroaki Shimoyamada, Michihiko Tajiri, Nobuo Ogawa, Munetaka Masuda, Hitoshi Kitamura.   

Abstract

We have established a concise sub-typing system suitable for predicting the postoperative outcome in cases of stage I lung adenocarcinoma (ADC), using morphometric profiling. The association between postoperative disease recurrence and a variety of morphological features including histological architecture, cell type, cytoplasmic color/internal structure, nuclear shape/size, chromatin pattern, and nucleoli count/remarkableness, was analyzed. Histological architecture had the most prognostic value and could be subdivided into low-grade (bronchioloalveolar, papillary and tubular: "tubular" in this paper is defined as a tubular or glandular structure lined with single-layered neoplastic cells) and high-grade (acinar and solid: "acinar" is defined as a tubular or glandular structure lined with poly-layered neoplastic cells or as a fused glandular structure such as the cribriform pattern) components. The subgroups separated based on a cut-off value, 71.5% of the high-grade component comprised by a tumor, which was calculated according to a relative operating characteristic curve, exhibited a significant difference in disease recurrence [estimated 5-year disease-free survival rate, 95.3% in the low-grade group versus 66.7% in the high-grade group, hazard ratio 7.35, Log-rank test p = 0.002]. The sub-grouping system is concise and suitable for practical use. It will improve the histological classification of ADC.

Entities:  

Keywords:  Lung adenocarcinoma; altered sub-typing system; morphometric profiling; prognostic value; stage I

Mesh:

Year:  2010        PMID: 20490327      PMCID: PMC2872743     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

Review 1.  Multidisciplinary management of lung cancer.

Authors:  Alexander Spira; David S Ettinger
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

2.  Long-term preservation of antigenicity on tissue microarrays.

Authors:  Kyle A DiVito; Lori A Charette; David L Rimm; Robert L Camp
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

3.  A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.

Authors:  Harubumi Kato; Yukito Ichinose; Morio Ohta; Enjo Hata; Noriaki Tsubota; Hirohito Tada; Yoh Watanabe; Hiromi Wada; Masahiro Tsuboi; Nobuyuki Hamajima; Mitsuo Ohta
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

4.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

5.  Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.

Authors:  Tomoshi Tsuchiya; Shinji Akamine; Masashi Muraoka; Ryotaro Kamohara; Koichi Tsuji; Shogo Urabe; Sumihisa Honda; Naoya Yamasaki
Journal:  Lung Cancer       Date:  2007-03-09       Impact factor: 5.705

6.  Variability of immunohistochemical reactivity on stored paraffin slides.

Authors:  P Bertheau; D Cazals-Hatem; V Meignin; A de Roquancourt; O Vérola; A Lesourd; C Séné; C Brocheriou; A Janin
Journal:  J Clin Pathol       Date:  1998-05       Impact factor: 3.411

7.  Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.

Authors:  S-H Ignatius Ou; Jason A Zell; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

8.  Morphometric profiling of lung cancers-its association with clinicopathologic, biologic, and molecular genetic features.

Authors:  Koji Okudela; Tetsukan Woo; Hideaki Mitsui; Takuya Yazawa; Hiroaki Shimoyamada; Michihiko Tajiri; Nobuo Ogawa; Munetaka Masuda; Hitoshi Kitamura
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

9.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis.

Authors:  M Noguchi; A Morikawa; M Kawasaki; Y Matsuno; T Yamada; S Hirohashi; H Kondo; Y Shimosato
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

10.  Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas.

Authors:  Tetsukan Woo; Koji Okudela; Takuya Yazawa; Nobuyuki Wada; Nobuo Ogawa; Naoki Ishiwa; Michihiko Tajiri; Yasushi Rino; Hitoshi Kitamura; Munetaka Masuda
Journal:  Lung Cancer       Date:  2009-01-21       Impact factor: 5.705

View more
  3 in total

Review 1.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

2.  Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.

Authors:  Luisa M Solis; Carmen Behrens; M Gabriela Raso; Heather Y Lin; Humam Kadara; Ping Yuan; Hector Galindo; Ximing Tang; J Jack Lee; Neda Kalhor; Ignacio I Wistuba; Cesar A Moran
Journal:  Cancer       Date:  2011-10-21       Impact factor: 6.860

3.  Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.

Authors:  DA-Ping Yu; Yu-Jie Dong; Hai-Qing Zhang; Jing-Hui Wang; Yang Qu; Li-Juan Zhou; Dan Su; Li-Li Zhang; Dan Zhao; Yi-Ran Cai
Journal:  Biomed Rep       Date:  2014-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.